BASF and Evolva enter into a collaboration to develop compounds applied to protect crops
“The collaboration with Evolva underlines BASF’s approach to employ cutting edge biotechnology for the development of new specialty products,” said Harald Lauke, President of the Specialty Chemicals Research at BASF.
The collaboration will initially cover two projects. BASF will pay Evolva an up-front technology access fee and ongoing research fees. BASF will have responsibility to take forward compounds produced during the collaboration and will potentially pay Evolva research and development milestone fees as well as royalties on products that result from the collaboration.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.